Relmada Therapeutics Announces Poster Presentations at the American Psychiatric Association Annual Meeting 2021 ...Middle East

NEW YORK, May 1, 2021 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that clinical data related to REL-1017, the company's lead product candidate, will be presented in...

Hence then, the article about relmada therapeutics announces poster presentations at the american psychiatric association annual meeting 2021 was published today ( Saturday 01/05/2021 - 03:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Relmada Therapeutics Announces Poster Presentations at the American Psychiatric Association Annual Meeting 2021 )

Also on site :

• Anycubic Opens Deposits for Kobra X, Following Formnext Debut of Its Next-Generation Entry-Level Multicolor FDM Printer
• Numbrix 9 - December 26
• Outsiders see a circular economy. CoreWeave’s CEO sees a ‘violent change’ rattling the supply chain down to the inside of the earth